References
- Carde P, Hagenbeek A, Hayat M, et al Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. J Clin Oncol 1993;11:2258–2272.
- Partridge S, Timothy A, O'Doherty MJ, Hain SF, Rankin S, Mikhaeel G. 2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution. Ann Oncol 2000;11:1273–1279.
- Weihrauch MR, Re D, Bischoff S, et al Whole-body positron emission tomography using 18F-fluorodeoxyglucose for initial staging of patients with Hodgkin's disease. Haematologica 2002;81:20–25.
- Naumann R, Beuthien-Baumann B, Reis A, et al Substantial impact of FDG PET imaging on the therapy decision in patients with early-stage Hodgkin's lymphoma. British Journal of Cancer. 2004;90:620–625.
- Hutchings M, Loft A, Hansen M, et al Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica. 2006;91:482–489.
- Zinzani P, Stefoni V, Tani M, et al Role of [18F]Fluorodeoxyglucose Positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 2009;27:1781–1787.
- Shulkin BL, Goodin GS, McCarville EB, et al Bone and [18F]Fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults.. Leuk Lymphoma 2009;50:1794–1802.
- Juweid ME, Stroobants S, Hoekstra OS, et al Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571–578.